Free Trial

Journey Medical (DERM) Competitors

Journey Medical logo
$7.46 -0.04 (-0.53%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$7.51 +0.05 (+0.67%)
As of 10/24/2025 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DERM vs. FBIO, RZLT, NRIX, DAWN, AKBA, OLMA, TYRA, TERN, TBPH, and ARVN

Should you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Fortress Biotech (FBIO), Rezolute (RZLT), Nurix Therapeutics (NRIX), Day One Biopharmaceuticals (DAWN), Akebia Therapeutics (AKBA), Olema Pharmaceuticals (OLMA), Tyra Biosciences (TYRA), Terns Pharmaceuticals (TERN), Theravance Biopharma (TBPH), and Arvinas (ARVN). These companies are all part of the "medical" sector.

Journey Medical vs. Its Competitors

Fortress Biotech (NASDAQ:FBIO) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

In the previous week, Fortress Biotech and Fortress Biotech both had 6 articles in the media. Journey Medical's average media sentiment score of 0.89 beat Fortress Biotech's score of 0.36 indicating that Journey Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fortress Biotech
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Journey Medical
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fortress Biotech currently has a consensus target price of $16.50, suggesting a potential upside of 557.37%. Journey Medical has a consensus target price of $12.17, suggesting a potential upside of 63.09%. Given Fortress Biotech's higher possible upside, equities analysts plainly believe Fortress Biotech is more favorable than Journey Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortress Biotech
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Journey Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Journey Medical has a net margin of -15.49% compared to Fortress Biotech's net margin of -24.84%. Journey Medical's return on equity of -48.69% beat Fortress Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Fortress Biotech-24.84% -301.81% -27.48%
Journey Medical -15.49%-48.69%-11.26%

96.5% of Fortress Biotech shares are held by institutional investors. Comparatively, 7.3% of Journey Medical shares are held by institutional investors. 27.9% of Fortress Biotech shares are held by insiders. Comparatively, 15.0% of Journey Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Journey Medical has lower revenue, but higher earnings than Fortress Biotech. Journey Medical is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$57.67M1.29-$46M-$1.05-2.39
Journey Medical$56.13M3.50-$14.67M-$0.38-19.63

Fortress Biotech has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500.

Summary

Journey Medical beats Fortress Biotech on 9 of the 15 factors compared between the two stocks.

Get Journey Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DERM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DERM vs. The Competition

MetricJourney MedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$196.27M$2.62B$6.21B$10.81B
Dividend YieldN/A57.77%5.72%4.80%
P/E Ratio-19.6328.3731.6030.98
Price / Sales3.50786.95595.06133.64
Price / CashN/A168.8137.2561.86
Price / Book8.205.6512.056.61
Net Income-$14.67M$33.06M$3.34B$277.10M
7 Day Performance3.61%3.16%1.94%2.57%
1 Month Performance5.67%7.06%6.88%3.20%
1 Year Performance29.51%-2.15%56.06%33.22%

Journey Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DERM
Journey Medical
1.902 of 5 stars
$7.46
-0.5%
$12.17
+63.1%
+29.5%$196.27M$56.13M-19.6390News Coverage
Analyst Forecast
FBIO
Fortress Biotech
2.7121 of 5 stars
$2.80
+3.3%
$16.50
+489.3%
+35.7%$80.64M$57.67M-2.67170News Coverage
Analyst Forecast
RZLT
Rezolute
2.6068 of 5 stars
$8.07
-2.4%
$14.50
+79.7%
+59.0%$751.15MN/A-8.3240News Coverage
Analyst Forecast
Gap Up
NRIX
Nurix Therapeutics
2.0887 of 5 stars
$9.72
-0.4%
$27.93
+187.3%
-57.8%$750.38M$54.55M-3.27300Trending News
Analyst Forecast
Analyst Revision
DAWN
Day One Biopharmaceuticals
2.9849 of 5 stars
$7.19
-0.7%
$25.29
+251.7%
-48.7%$741.61M$131.16M-7.5760
AKBA
Akebia Therapeutics
3.5152 of 5 stars
$2.78
+1.1%
$6.75
+142.8%
+90.6%$729.15M$160.18M-16.35430Analyst Forecast
OLMA
Olema Pharmaceuticals
3.1215 of 5 stars
$10.75
+1.7%
$23.33
+117.1%
-30.5%$725.47MN/A-5.4370Analyst Forecast
Gap Down
TYRA
Tyra Biosciences
2.4122 of 5 stars
$14.36
+6.2%
$31.86
+121.8%
-35.1%$720.58MN/A-8.0720Analyst Forecast
TERN
Terns Pharmaceuticals
4.02 of 5 stars
$8.20
+0.6%
$15.49
+88.9%
+16.5%$713.22MN/A-7.8840News Coverage
Analyst Forecast
TBPH
Theravance Biopharma
2.1598 of 5 stars
$13.92
-0.5%
$23.00
+65.2%
+67.0%$704.55M$64.38M58.00110News Coverage
Analyst Forecast
ARVN
Arvinas
3.6087 of 5 stars
$9.80
+3.6%
$16.29
+66.2%
-64.5%$694.53M$263.40M-9.70420News Coverage
Upcoming Earnings
Analyst Forecast
High Trading Volume

Related Companies and Tools


This page (NASDAQ:DERM) was last updated on 10/26/2025 by MarketBeat.com Staff
From Our Partners